Zobrazeno 1 - 10
of 261
pro vyhledávání: '"N. Senzer"'
Autor:
Stephen M.F. Jamieson, Peter Tsai, Maria K. Kondratyev, Pratha Budhani, Arthur Liu, Neil N. Senzer, E. Gabriela Chiorean, Shadia I. Jalal, John J. Nemunaitis, Dennis Kee, Avik Shome, Way W. Wong, Dan Li, Nooriyah Poonawala-Lohani, Purvi M. Kakadia, Nicholas S. Knowlton, Courtney R.H. Lynch, Cho R. Hong, Tet Woo Lee, Reidar A. Grénman, Laura Caporiccio, Trevor D. McKee, Mark Zaidi, Sehrish Butt, Andrew M.J. Macann, Nicholas P. McIvor, John M. Chaplin, Kevin O. Hicks, Stefan K. Bohlander, Bradly G. Wouters, Charles P. Hart, Cristin G. Print, William R. Wilson, Michael A. Curran, Francis W. Hunter
Publikováno v:
JCI Insight, Vol 8, Iss 4 (2023)
Externí odkaz:
https://doaj.org/article/b8265d5c0ed44e2583f6823d2b9a7cc0
Autor:
Paul L. Hallenbeck, Christine L. Hann, P. Seshidhar Reddy, Kevin D. Burroughs, David Loesch, Joseph Stephenson, Neil N. Senzer, John T. Poirier, Charles M. Rudin
Purpose: Seneca Valley Virus (SVV-001) is a novel naturally occurring replication-competent picornavirus with potent and selective tropism for neuroendocrine cancer cell types, including small cell lung cancer. We conducted a first-in-human, first-in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69ceb98e7a80db18ee1e10421bf2db27
https://doi.org/10.1158/1078-0432.c.6518800.v1
https://doi.org/10.1158/1078-0432.c.6518800.v1
Autor:
Paul L. Hallenbeck, Christine L. Hann, P. Seshidhar Reddy, Kevin D. Burroughs, David Loesch, Joseph Stephenson, Neil N. Senzer, John T. Poirier, Charles M. Rudin
Supplementary Figure S1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fa2dd5ae0559aaa2fd3aab24639d7a0
https://doi.org/10.1158/1078-0432.22441945.v1
https://doi.org/10.1158/1078-0432.22441945.v1
Publikováno v:
Drug Target Insights, Vol 3, Pp 55-66 (2008)
The rapidly expanding data sets derived from genomic and transcriptomic analyses have allowed greater understanding of structural and functional network patterns within the genome resulting in a realignment of thinking within a systems biologic frame
Externí odkaz:
https://doaj.org/article/115225826edc49e1af3cba8c7c540db5
Publikováno v:
Drug Target Insights, Vol 3, Iss 1 (2008)
Abstract non disponibile
Externí odkaz:
https://doaj.org/article/abbd65ed6b3440e1b22bcabcb36be819
Autor:
Emily Chan, Jeffrey W. Clark, Carl L. Berg, Amanda Carpenter, David P. Ryan, Scott J. Cotler, Douglas M. Heuman, Neil N. Senzer, Jordan Berlin, Keith Stuart, Jeffrey G. Supko, Sarah L. Hilderbrand, Aram F. Hezel, Lawrence S. Blaszkowsky, Lipika Goyal, Andrew X. Zhu
Publikováno v:
Cancer Chemotherapy and Pharmacology. 72:1305-1314
N 1,N 11-diethylnorspermine (DENSPM), a synthetic analog of the naturally occurring polyamine spermine, can induce polyamine depletion and inhibit tumor cell growth. The objectives of this phase I study were to assess the safety, maximum-tolerated do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48f07a6b1acb179806d01e7fe5770603
https://doi.org/10.1007/s00280-013-2293-8
https://doi.org/10.1007/s00280-013-2293-8
Autor:
Phillip B. Maples, J Olivares, N Senzer, P Kumar, John Nemunaitis, B O Pappen, Minal A. Barve, T Nemunaitis, J Kuhn, M Magee, G Wallraven, Y Yu
Publikováno v:
Gene Therapy. 20:875-879
TAG vaccine is a novel 'triad vaccine' that involves transfection of autologous tumor with a dual plasmid, TGFβ2 antisense gene and GM-CSF gene. Patients with advanced cancer who failed standard therapy were treated. IFN-γ ELISPOT analysis (Enzyme-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::461907bf4676476fa5ba45100db6ed7c
https://doi.org/10.1038/gt.2013.9
https://doi.org/10.1038/gt.2013.9
Autor:
Bert L. Lum, Daniel A. Laheru, Theresa Rogers, N. Senzer, Wells A. Messersmith, Manuel Hidalgo, Sean K. Kelley, David Ramies, Paula Grouleff, Ross C. Donehower
Publikováno v:
Clinical Cancer Research. 10:6522-6527
Purpose: This phase I study was conducted to establish the dose-limiting toxicities and maximum-tolerated dose of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in combination with FOLFIRI, a standard regimen of irinot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99ff6a2e614e44d43a4bc956e25e1769
https://doi.org/10.1158/1078-0432.ccr-04-0746
https://doi.org/10.1158/1078-0432.ccr-04-0746
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Neil N. Senzer
Publikováno v:
Seminars in Oncology. 28:77-85
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36bbd16ddb0c72f267fe60b9a4ca7461
https://doi.org/10.1053/sonc.2001.27199
https://doi.org/10.1053/sonc.2001.27199